Skip to main content

Advertisement

SpringerLink
Log in

Radikale Zystektomie vs. Radiochemotherapie zur Behandlung des Blasenkarzinoms im Stadium T2–4a N0 M0

Radical cystectomy vs. chemoradiation for the treatment of T2–4a N0 M0 bladder cancer

  • Literatur kommentiert
  • Published:
Strahlentherapie und Onkologie Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Bellmunt J, Orsola A, Leow JJ et al (2014) Bladder Cancer: ESMO Practice Guidelines fpr diagnosis, treatment and follow up. Ann Oncol 25(Suppl 3):iii40–iii48

  2. Gofrit ON, Nof R, Meirovitz A et al (2015) Radical cystectomy vs. chemoradiation in T2-4aN0M0 bladder cancer: A case-control study. Urol Oncol 33:19.e1–19.e5

    Article  Google Scholar 

  3. Krause FS, Walter B, Ott OJ, Häberle L et al (2011) 15 year survival rates after transurethral resection and radiochemotherapy or radiation in bladder cancer treatment. Anticancer Res 31:985–990

    PubMed  Google Scholar 

  4. Mak RH, Hunt D, Shipley WU et al (2014) Long-term outcomes in patients with Muscle-Invasive bladder cancer after selective bladder-preserving combined-modality therapy: a pooled analysis of Radiation Therapy Oncology Group Protocols 8802, 8903, 9506, 9706, 9906, and 0233. J Clin Oncol 32:3801–3809

    Article  PubMed  PubMed Central  Google Scholar 

  5. Mitin T, Hunt D, Shipley WU et al (2013) Transurethral surgery and twice-daily radiation plus paclitaxel-cisplatin or fluorouracil-cisplatin with selective bladder preservation and adjuvant chemotherapy for patients with muscleinvasive bladder cancer (RTOG 0233): a randomised multicentre phase 2 trial. Lancet Oncol 14:863–872

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Weiss C, Engehausen DG, Krause FS et al (2007) Radiochemotherapy with cisplatin and 5‑fluorouracil after transurethral surgery in patients with bladder cancer. Int J Radiat Oncol Biol Phys 68:1072–1080

    Article  CAS  PubMed  Google Scholar 

  7. Wittlinger W, Rödel CM, Weiss C et al (2009) Quadrimodal treatment of high-risk T1 and T2 bladder cancer: Transurethral tumor resection followed by concurrent radiochemotherapy and regional deep hyperthermia. Radiother Oncol 93:358–363

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klinikum Chemnitz gGmbH, Flemmingstraße 2, 09116, Chemnitz, Deutschland

    Gunther Klautke

Authors
  1. Gunther Klautke
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Gunther Klautke.

Additional information

Originalpublikation Gofrit ON, Nof R, Meirovitz A et al (2015) Radical cystectomy vs. chemoradiation in T2–4a N0 M0 bladder cancer: A case-control study. Urol Oncol 33 (1)19e1–19e

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Klautke, G. Radikale Zystektomie vs. Radiochemotherapie zur Behandlung des Blasenkarzinoms im Stadium T2–4a N0 M0. Strahlenther Onkol 192, 823–824 (2016). https://doi.org/10.1007/s00066-016-1043-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00066-016-1043-3

Search

Navigation